JP2001521020A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521020A5
JP2001521020A5 JP2000517936A JP2000517936A JP2001521020A5 JP 2001521020 A5 JP2001521020 A5 JP 2001521020A5 JP 2000517936 A JP2000517936 A JP 2000517936A JP 2000517936 A JP2000517936 A JP 2000517936A JP 2001521020 A5 JP2001521020 A5 JP 2001521020A5
Authority
JP
Japan
Prior art keywords
acetic acid
aminomethyl
cyclopentyl
methyl
cyclobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000517936A
Other languages
English (en)
Japanese (ja)
Other versions
JP3756761B2 (ja
JP2001521020A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/019876 external-priority patent/WO1999021824A1/en
Publication of JP2001521020A publication Critical patent/JP2001521020A/ja
Publication of JP2001521020A5 publication Critical patent/JP2001521020A5/ja
Application granted granted Critical
Publication of JP3756761B2 publication Critical patent/JP3756761B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000517936A 1997-10-27 1998-09-23 医薬として有用な環状アミノ酸およびその誘導体 Expired - Fee Related JP3756761B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6364497P 1997-10-27 1997-10-27
US60/063,644 1997-10-27
US9768598P 1998-08-24 1998-08-24
US60/097,685 1998-08-24
PCT/US1998/019876 WO1999021824A1 (en) 1997-10-27 1998-09-23 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005319009A Division JP4263717B2 (ja) 1997-10-27 2005-11-02 医薬として有用な環状アミノ酸およびその誘導体

Publications (3)

Publication Number Publication Date
JP2001521020A JP2001521020A (ja) 2001-11-06
JP2001521020A5 true JP2001521020A5 (https=) 2006-01-05
JP3756761B2 JP3756761B2 (ja) 2006-03-15

Family

ID=26743626

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000517936A Expired - Fee Related JP3756761B2 (ja) 1997-10-27 1998-09-23 医薬として有用な環状アミノ酸およびその誘導体
JP2005319009A Expired - Fee Related JP4263717B2 (ja) 1997-10-27 2005-11-02 医薬として有用な環状アミノ酸およびその誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005319009A Expired - Fee Related JP4263717B2 (ja) 1997-10-27 2005-11-02 医薬として有用な環状アミノ酸およびその誘導体

Country Status (30)

Country Link
US (3) US6635673B1 (https=)
EP (1) EP1032555B1 (https=)
JP (2) JP3756761B2 (https=)
KR (1) KR100589066B1 (https=)
CN (2) CN1303059C (https=)
AR (1) AR013726A1 (https=)
AT (1) ATE323067T1 (https=)
AU (1) AU755800B2 (https=)
BR (1) BR9813284B1 (https=)
CA (1) CA2303244C (https=)
CO (1) CO5280097A1 (https=)
CU (1) CU23048A3 (https=)
CY (1) CY1105062T1 (https=)
DE (1) DE69834204T2 (https=)
DK (1) DK1032555T3 (https=)
ES (1) ES2260850T3 (https=)
GE (1) GEP20094817B (https=)
HU (1) HUP0004310A3 (https=)
IL (1) IL134732A (https=)
IS (1) IS2489B (https=)
NO (1) NO327671B1 (https=)
NZ (1) NZ503651A (https=)
PE (1) PE122799A1 (https=)
PL (2) PL199794B1 (https=)
PT (1) PT1032555E (https=)
SI (1) SI1032555T1 (https=)
TR (1) TR200001170T2 (https=)
UY (1) UY25223A1 (https=)
WO (1) WO1999021824A1 (https=)
ZA (1) ZA989740B (https=)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225502B1 (en) * 1998-12-29 2007-01-29 Richter Gedeon Vegyeszet Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
ES2228524T3 (es) * 1999-05-26 2005-04-16 Warner-Lambert Company Llc Aminoacidos policiclicos fundidos utilizados como agentes farmaceuticos.
EP1840117A1 (en) * 1999-06-10 2007-10-03 Warner-Lambert Company LLC Mono- and disubstituted 3-propyl gamma-aminobutyric acids
US6642398B2 (en) 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
ES2317839T3 (es) * 1999-06-10 2009-05-01 Warner-Lambert Company Llc Acidos 3-propil gamma-aminobutiricos monosustituidos.
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
HN2000000224A (es) 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
US6864390B2 (en) 1999-12-08 2005-03-08 Warner-Lambert Company Method for the stereoselective synthesis of cyclic amino acids
CN1607201A (zh) * 1999-12-08 2005-04-20 沃尼尔·朗伯公司 立体选择性地合成环状氨基酸的方法
GB2362646A (en) * 2000-05-26 2001-11-28 Warner Lambert Co Cyclic amino acid derivatives useful as pharmaceutical agents
IL152770A0 (en) * 2000-06-26 2003-06-24 Warner Lambert Co Gabapentin analogues for sleep disorders
GB2364049A (en) * 2000-06-28 2002-01-16 Warner Lambert Co Cyclic ketones and their use in the synthesis of amino acids
EP1361847A2 (en) 2000-10-06 2003-11-19 Xenoport, Inc. Bile-acid conjugates for providing sustained systemic concentrations of drugs
WO2002028881A1 (en) 2000-10-06 2002-04-11 Xenoport, Inc. Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
EP1226820A1 (en) 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
GB2374595A (en) * 2001-04-19 2002-10-23 Warner Lambert Co Fused bicyclic or tricyclic amino acids
SK12822003A3 (sk) * 2001-04-19 2004-04-06 Warner - Lambert Company Llc Fúzne bicyklické alebo tricyklické aminokyseliny
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7420002B2 (en) 2001-06-11 2008-09-02 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
ATE540678T1 (de) 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
WO2003077902A1 (en) 2002-02-19 2003-09-25 Xenoport, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
AU2003222033A1 (en) 2002-03-20 2003-10-08 Xenoport Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
WO2003099338A2 (en) 2002-05-17 2003-12-04 Xenoport, Inc. Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
GB0223072D0 (en) * 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
WO2004052360A1 (en) 2002-12-11 2004-06-24 Xenoport, Inc. Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
BR0317253A (pt) 2002-12-13 2005-11-01 Warner Lambert Co Derivados pregabalina para o tratamento da fibromialgia e outras patologias
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PL377286A1 (pl) * 2002-12-13 2006-01-23 Warner-Lambert Company Llc Analogi gabapentyny do włókniako-mięśniakowych i innych pokrewnych zaburzeń
WO2005002585A1 (en) * 2003-07-02 2005-01-13 Warner-Lambert Company Llc Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
KR20060119971A (ko) 2003-09-11 2006-11-24 제노포트 인코포레이티드 Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
NZ545494A (en) 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
AU2004274002B2 (en) 2003-09-17 2011-04-28 Arbor Pharmaceuticals, Llc Treating or preventing restless legs syndrome using prodrugs of GABA analogs
PT1677767E (pt) 2003-10-14 2011-10-13 Xenoport Inc Forma cristalina de análogo de ácido gama-aminobutírico
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CA2584338C (en) 2004-11-04 2013-08-06 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
WO2007010387A2 (en) * 2005-07-18 2007-01-25 Pharmacia & Upjohn Company Llc Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
CN101420947A (zh) * 2006-03-06 2009-04-29 辉瑞产品公司 用于非恢复性睡眠的α-2-δ配体
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
CA2673545A1 (en) 2006-12-22 2008-07-03 Recordati Ireland Limited Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
WO2008155619A2 (en) * 2007-06-21 2008-12-24 Pfizer Inc. Preparation of optically-active cyclic amino acids
BRPI0818193B8 (pt) 2007-09-28 2021-05-25 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso de um composto
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
CA2706575C (en) 2008-01-25 2015-07-14 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
CN105330603A (zh) 2008-10-08 2016-02-17 凯飞药业公司 Gaba偶联物及其使用方法
JP5557292B2 (ja) 2009-03-26 2014-07-23 第一三共株式会社 二環性γ−アミノ酸誘導体の製造方法
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
ES2659162T3 (es) 2011-06-08 2018-03-14 Daiichi Sankyo Company, Limited Procedimiento de producción de compuesto bicíclico a través de una sal de iminio
HUE035366T2 (en) 2011-06-08 2018-05-02 Daiichi Sankyo Co Ltd A method for the preparation of a bicyclic compound by Claisen rearrangement
KR101944575B1 (ko) 2011-12-15 2019-04-17 다이이찌 산쿄 가부시키가이샤 부제 촉매를 사용하는 2고리형 화합물의 광학 분할 방법
EP2837689B1 (en) 2012-04-10 2017-02-15 Daiichi Sankyo Company, Limited Optical resolution method for bicyclic compound using enzyme
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
CA2903000C (en) 2013-01-28 2021-10-12 Hector L. Lopez Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ－胺基酸衍生物及其製造方法
TW201607538A (zh) 2013-12-17 2016-03-01 以斯提夫博士實驗室股份有限公司 血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物
WO2015091505A1 (en) 2013-12-17 2015-06-25 Laboratorios Del Dr. Esteve, S.A. Gabapentinoids and sigma receptor ligands combinations
CN112424158A (zh) 2018-05-14 2021-02-26 昌郁医药公司 萘普生和普瑞巴林的1-(酰氧基)-烷基氨基甲酸酯药物缀合物的结晶形式
TWI808217B (zh) 2018-07-12 2023-07-11 大陸商四川海思科製藥有限公司 稠合三環γ-胺基酸衍生物之組合物及其製備方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2611690A1 (de) 1976-03-19 1977-09-22 Goedecke Ag Cyclische sulfonyloxyimide
CA1085420A (en) 1977-03-24 1980-09-09 Johannes Hartenstein 1-aminomethyl-1-cycloalkane-acetic acid
US5132451A (en) 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
US5319135A (en) 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
EP0458751A1 (en) 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
DE69116499T2 (de) 1990-10-20 1996-08-22 Takasago Perfumery Co Ltd Verfahren zur Herstellung von Alpha-Hydroxyketonen
JP3333510B2 (ja) 1991-10-02 2002-10-15 スミスクライン・ビーチャム・コーポレイション 抗アレルギー、抗炎症および腫瘍壊死因子抑制活性を有するシクロペンタンおよびシクロペンテン誘導体
US5631291A (en) 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
DE4400749A1 (de) 1994-01-13 1995-07-20 Bayer Ag Neues hochenantioselektives Verfahren zur Herstellung von enantiomerenreinen Cyclopentan- und -penten-beta-Aminosäuren
RU2168982C2 (ru) 1994-07-27 2001-06-20 Варнер-Ламберт Компани Способ лечения состояния страха или лечения и/или предупреждения состояния паники, очищенный белок, способный связывать габапентин, и фармацевтическая композиция, обладающая успокоительным, противопаническим и противосудорожным действием
US5510381A (en) 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
HU224720B1 (en) * 1996-03-14 2006-01-30 Warner Lambert Co Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
HRP980342A2 (en) 1997-06-25 1999-02-28 Warner Lambert Co Anti-inflammatory method
US9858641B2 (en) * 2014-12-15 2018-01-02 International Business Machines Corporation Representing a system using viewpoints
US9419648B1 (en) * 2015-09-18 2016-08-16 Intel Corporation Supporting data compression using match scoring

Similar Documents

Publication Publication Date Title
JP2001521020A5 (https=)
EP0641330B1 (en) Gaba and l-glutamic acid analogs for antiseizure treatment
EP0082088B1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
US6262120B1 (en) GABA and L-glutamic acid analogs for antiseizure treatment
KR100694735B1 (ko) 일치환 및 이치환된 3-프로필 감마-아미노부티르산
MC1232A1 (fr) Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes
EP0318377A2 (fr) Nouveaux composés énantiomères dérivés d'amino-acides, leur procédé de préparation et leurs applications thérapeutiques
JP2006515587A5 (https=)
EP1009750B1 (fr) Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et leurs applications therapeutiques
EP0362001A1 (fr) N-cycloalkylalkyle benzylamines alpha,alpha disubstituées, leur procédé de préparation, leur utilisation comme médicament et leurs intermédiaires de synthèse
EP0639586B1 (fr) Dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JP3576193B2 (ja) ビフェニルメチル置換バレリルアミド誘導体
JPH02233650A (ja) 新規なテトラリン誘導体
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
JP3084345B2 (ja) 光学活性な２−プロピルオクタン酸の製造方法
WO2009022839A2 (en) Novel method for preparing pregabalin
JP2778103B2 (ja) 光学活性なスレオージヒドロキシフェニルセリン誘導体の製造方法
IE56654B1 (en) A process for the resolution of racemates of optically active bicyclic imino-alpha-carboxylic esters,and the use of the compounds thus obtainable for the synthesis of carboxyalkyldipeptides
EP1073664B1 (fr) Derives d'(alpha-aminophosphino) peptides et compositions les contenant
KR100225829B1 (ko) 라세미성 1,2,3,4-테트라하이드로이소퀴놀린-3-카복실산 및 광학 활성 1,2,3,4-테트라하이드로이소퀴놀린-3-카복실산의 제조방법
EP0869952B1 (fr) Derives de 5-naphtalen-1-y1-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2602511A1 (fr) Peptides et derives peptidiques, leur preparation et leur utilisation comme medicaments
EP4725937A1 (en) Process for the synthesis of bicyclic carboxamide compounds
EP0347313B1 (fr) Ethers de la 2-amino-7-hydroxytétraline
CA2261843A1 (fr) Derives du thienylcyclohexane pour la synthese de thienylcyclohexyles